September 14, 2026

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a 10.92% Potential Downside Amidst Healthcare Sector Innovations

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a prominent player in the healthcare sector, specifically within the medical devices industry. Headquartered in Hercules, California, the company..

Ionis Pharmaceuticals (IONS) Stock Analysis: Biotechnology Player with 55% Upside Potential and Strong Analyst Confidence

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) operates at the forefront of the biotechnology sector, specializing in RNA-targeted medicines. Despite the challenges reflected in its recent financial performance,..

Bruker Corporation (BRKR) Stock Analysis: Evaluating Growth Potential with a 10.86% Upside

Bruker Corporation (NASDAQ: BRKR), a key player in the healthcare sector specializing in medical devices, offers investors an intriguing opportunity with a projected potential upside of..

AbbVie Inc. (ABBV) Stock Analysis: A $454 Billion Giant with Upside Potential and Strong Buy Ratings

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, continues to capture investor attention with its robust portfolio and promising growth trajectory. Operating within the..

Medpace Holdings, Inc. (MEDP) Stock Analysis: A Resilient Growth Story with a Strong ROE

Medpace Holdings, Inc. (NASDAQ: MEDP) is carving out a formidable presence in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unveiling an 18% Potential Upside in Healthcare Solutions

Stevanato Group S.p.A. (STVN), a prominent player in the healthcare sector, is drawing attention from investors with a significant 18.06% potential upside in its stock price...

Oscar Health, Inc. (OSCR) Stock Analysis: Riding a 70.4% Revenue Growth Wave in the Healthcare Sector

Oscar Health, Inc. (NYSE: OSCR) has made waves in the healthcare sector with its innovative approach to health insurance and technology integration. Operating in the U.S...

Tempus AI, Inc. (TEM): Investor Outlook with a 15.53% Upside Potential

Tempus AI, Inc. (NASDAQ: TEM), a prominent player in the healthcare technology sector, is drawing attention from investors due to its innovative platforms and strategic partnerships...

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating Market Challenges with a 17.97% ROE

Inspire Medical Systems, Inc. (NASDAQ: INSP) continues to capture the attention of investors within the healthcare sector, particularly those focused on medical devices. With a market..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a 160% Potential Upside with Innovative Therapies

For investors with an eye on the healthcare sector, Legend Biotech Corporation (NASDAQ: LEGN) presents a compelling opportunity, especially considering the staggering 160.08% potential upside based..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Gem with a 29% Upside Potential

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, has garnered significant attention with its strategic focus on B-cell mediated diseases. With a..

Elanco Animal Health (ELAN) Stock Analysis: Exploring a 34.72% Potential Upside

Elanco Animal Health Incorporated (NYSE: ELAN), a key player in the healthcare sector specializing in animal health, presents an intriguing opportunity for investors with its significant..

AptarGroup, Inc. (ATR) Investor Outlook: Assessing a 36% Potential Upside in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR), a prominent player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $7.94 billion,..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 43.91% Potential Upside Amidst a Challenging Market

Grifols, S.A. (NASDAQ: GRFS), a key player in the healthcare sector specializing in the manufacture of plasma-derived medicines, stands at a pivotal point in its market..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: A Promising 58% Upside for Healthcare Innovators

iRhythm Holdings, Inc. (NASDAQ: IRTC) presents an intriguing opportunity for investors, particularly those interested in the healthcare sector’s innovative edge. This San Francisco-based company specializes in..

Corcept Therapeutics (CORT) Stock Analysis: Uncovering a 25% Potential Upside in the Biotech Sector

Corcept Therapeutics Incorporated (CORT), a prominent player in the biotechnology industry, is garnering attention for its innovative approach to treating severe endocrinologic, oncologic, metabolic, and neurologic..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: An 18% Upside Potential Beckons Investors

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotech industry, is capturing investor attention with a compelling growth trajectory and a robust portfolio of..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A 38% Potential Upside for Investors

IDEXX Laboratories, Inc. (NASDAQ: IDXX) is making waves in the healthcare sector, particularly within the Diagnostics & Research industry. With a formidable market cap of $39.76..

Globus Medical, Inc. (GMED) Stock Analysis: Navigating a 39% Potential Upside in the Medical Devices Sector

For investors seeking opportunities in the healthcare sector, particularly within the burgeoning field of medical devices, Globus Medical, Inc. (NYSE: GMED) presents a compelling case. With..

Boston Scientific Corporation (BSX) Stock Analysis: Exploring a 45% Upside Potential

Boston Scientific Corporation (NYSE: BSX) stands as a formidable player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $62.29..

Search

Funds

September 14, 2026

Search

Funds

September 14, 2026

FTSE 100

Funds